The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

A powerful new synthetic opioid, up to 1000 times stronger than morphine, has emerged in Adelaide’s street drug supply, and ...

Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Routinely offering and initiating medication-based treatment for those with opioid use disorder has the potential to save ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not ...

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...

The proportion of patients who receive a long-term opioid prescription following colorectal surgery has significantly ...

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

• La Crosse County Board will vote Thursday on expanding the Pathways Home Program with a $350,000 state grant • Funding would allow the program to hire a seventh social worker to assist ...

Lifestyle interventions combining diet and exercise may influence metabolic pathways that are linked to improved cardiometabolic risk among older adults with rheumatoid arthritis (RA) and ...